129 related articles for article (PubMed ID: 10843190)
1. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
J Clin Endocrinol Metab; 2000 May; 85(5):2014-9. PubMed ID: 10843190
[TBL] [Abstract][Full Text] [Related]
2. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B
J Clin Endocrinol Metab; 1999 Mar; 84(3):1077-82. PubMed ID: 10084598
[TBL] [Abstract][Full Text] [Related]
3. The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B; Connelly PW
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):217-22. PubMed ID: 10634821
[TBL] [Abstract][Full Text] [Related]
4. Gender, obesity, hepatic nuclear factor-1alpha G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Cao H; Harris SB; Zinman B; Hanley AJ; Anderson CM
Int J Obes Relat Metab Disord; 2000 Aug; 24(8):1062-4. PubMed ID: 10951547
[TBL] [Abstract][Full Text] [Related]
5. Genes, environment and Oji-Cree type 2 diabetes.
Hegele RA; Zinman B; Hanley AJ; Harris SB; Barrett PH; Cao H
Clin Biochem; 2003 May; 36(3):163-70. PubMed ID: 12726923
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians.
Hegele RA; Cao H; Hanley AJ; Zinman B; Harris SB; Anderson CM
Diabetes Care; 2000 Jun; 23(6):775-8. PubMed ID: 10840995
[TBL] [Abstract][Full Text] [Related]
7. Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree.
Hegele RA; Hanley AJ; Zinman B; Harris SB; Anderson CM
J Hum Genet; 2000; 45(3):184-7. PubMed ID: 10807546
[TBL] [Abstract][Full Text] [Related]
8. HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community.
Triggs-Raine BL; Kirkpatrick RD; Kelly SL; Norquay LD; Cattini PA; Yamagata K; Hanley AJ; Zinman B; Harris SB; Barrett PH; Hegele RA
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4614-9. PubMed ID: 11904371
[TBL] [Abstract][Full Text] [Related]
9. Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes.
Pollex RL; Hanley AJ; Zinman B; Harris SB; Khan HM; Hegele RA
Diabet Med; 2005 Nov; 22(11):1510-5. PubMed ID: 16241915
[TBL] [Abstract][Full Text] [Related]
10. [HNF-1alpha G319S mutation in Oji-Cree type 2 diabetes].
Yamagata K
Nihon Rinsho; 2005 Feb; 63 Suppl 2():171-5. PubMed ID: 15779364
[No Abstract] [Full Text] [Related]
11. Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population.
Pollex RL; Hanley AJ; Zinman B; Harris SB; Hegele RA
Int J Obes (Lond); 2006 Mar; 30(3):484-91. PubMed ID: 16276364
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes.
Pollex RL; Mamakeesick M; Zinman B; Harris SB; Hegele RA; Hanley AJ
J Diabetes Complications; 2007; 21(3):166-71. PubMed ID: 17493550
[TBL] [Abstract][Full Text] [Related]
13. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte nuclear factor-1 alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes.
Hegele RA; Cao H; Harris SB; Hanley AJ; Zinman B
Diabetes Care; 1999 Mar; 22(3):524. PubMed ID: 10097940
[No Abstract] [Full Text] [Related]
15. Diabetes susceptibility in the Canadian Oji-Cree population is moderated by abnormal mRNA processing of HNF1A G319S transcripts.
Harries LW; Sloman MJ; Sellers EA; Hattersley AT; Ellard S
Diabetes; 2008 Jul; 57(7):1978-82. PubMed ID: 18586913
[TBL] [Abstract][Full Text] [Related]
16. NAT2 polymorphism associated with plasma glucose concentration in Canadian Oji-Cree.
Hegele RA; Kwan K; Harris SB; Hanley AJ; Zinman B; Cao H
Pharmacogenetics; 2000 Apr; 10(3):233-8. PubMed ID: 10803679
[TBL] [Abstract][Full Text] [Related]
17. The ADD1 G460W polymorphism is not associated with variation in blood pressure in Canadian Oji-Cree.
Busch CP; Harris SB; Hanley AJ; Zinman B; Hegele RA
J Hum Genet; 1999; 44(4):225-9. PubMed ID: 10429360
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers.
Hegele RA; Sun F; Harris SB; Anderson C; Hanley AJ; Zinman B
J Hum Genet; 1999; 44(1):10-4. PubMed ID: 9929969
[TBL] [Abstract][Full Text] [Related]
19. Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes.
Evans D; de Heer J; Hagemann C; Wendt D; Wolf A; Beisiegel U; Mann WA
Exp Clin Endocrinol Diabetes; 2001; 109(3):151-4. PubMed ID: 11409297
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of the HNF-1alpha G319S mutation in Canadian aboriginal youth with type 2 diabetes.
Sellers EA; Triggs-Raine B; Rockman-Greenberg C; Dean HJ
Diabetes Care; 2002 Dec; 25(12):2202-6. PubMed ID: 12453961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
